• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇与亚油酸共轭新型胶束负载6-姜辣素的口服生物利用度增强、抗肿瘤活性及肝保护作用

Enhanced Oral Bioavailability, Anti-Tumor Activity and Hepatoprotective Effect of 6-Shogaol Loaded in a Type of Novel Micelles of Polyethylene Glycol and Linoleic Acid Conjugate.

作者信息

Zhang Huiyun, Wang Qilong, Sun Congyong, Zhu Yuan, Yang Qiuxuan, Wei Qiuyu, Chen Jiaxin, Deng Wenwen, Adu-Frimpong Michael, Yu Jiangnan, Xu Ximing

机构信息

Center for Nano Drug/Gene Delivery and Tissue Engineering, Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.

出版信息

Pharmaceutics. 2019 Mar 6;11(3):107. doi: 10.3390/pharmaceutics11030107.

DOI:10.3390/pharmaceutics11030107
PMID:30845761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6470752/
Abstract

:6-shogaol is a promising anti-cancer and anti-inflammatory agent. However, the treatment effectiveness of 6-shogaol is limited by poor water solubility, poor oral absorption and rapid metabolism. Herein, 6-shogaol loaded in micelles (SMs) were designed to improve 6-shogaol's solubility and bioavailability. The micelles of a PEG derivative of linoleic acid (mPEG-LA) were prepared by the nanoprecipitation method with a particle size of 76.8 nm, and entrapment of 81.6 %. Intriguingly, SMs showed a slower release in phosphate buffer saline (PBS) (pH = 7.4) compared to free 6-shogaol while its oral bioavailability increased by 3.2⁻fold in vivo. More importantly, the in vitro cytotoxic effect in HepG2 cells of SMs was significantly higher than free 6-shogaol. Furthermore, SMs could significantly improve the tissue distribution of 6-shogaol, especially liver and brain. Finally, SMs showed a better hepatoprotective effect against carbon tetrachloride (CCl4)-induced hepatic injury in vivo than free 6-shogaol. These results suggest that the novel micelles could potentiate the activities of 6-shogaol in cancer treatment and hepatoprotection.

摘要

6-姜辣素是一种很有前景的抗癌和抗炎药物。然而,6-姜辣素的治疗效果受到其水溶性差、口服吸收不良和代谢迅速的限制。在此,设计了负载6-姜辣素的胶束(SMs)以提高6-姜辣素的溶解度和生物利用度。通过纳米沉淀法制备了亚油酸聚乙二醇衍生物(mPEG-LA)胶束,粒径为76.8 nm,包封率为81.6%。有趣的是,与游离6-姜辣素相比,SMs在磷酸盐缓冲盐水(PBS,pH = 7.4)中的释放较慢,而其体内口服生物利用度提高了3.2倍。更重要的是,SMs在HepG2细胞中的体外细胞毒性作用明显高于游离6-姜辣素。此外,SMs可以显著改善6-姜辣素的组织分布,尤其是肝脏和大脑。最后,在体内,SMs对四氯化碳(CCl4)诱导的肝损伤显示出比游离6-姜辣素更好的肝保护作用。这些结果表明,这种新型胶束可以增强6-姜辣素在癌症治疗和肝保护方面的活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a2/6470752/8e365b220668/pharmaceutics-11-00107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a2/6470752/8e365b220668/pharmaceutics-11-00107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a2/6470752/8e365b220668/pharmaceutics-11-00107-g001.jpg

相似文献

1
Enhanced Oral Bioavailability, Anti-Tumor Activity and Hepatoprotective Effect of 6-Shogaol Loaded in a Type of Novel Micelles of Polyethylene Glycol and Linoleic Acid Conjugate.聚乙二醇与亚油酸共轭新型胶束负载6-姜辣素的口服生物利用度增强、抗肿瘤活性及肝保护作用
Pharmaceutics. 2019 Mar 6;11(3):107. doi: 10.3390/pharmaceutics11030107.
2
Anti-hyperuricemic property of 6-shogaol via self-micro emulsifying drug delivery system in model rats: formulation design, and evaluation.6-姜烯酚自微乳给药系统对模型大鼠的降血尿酸作用:制剂设计与评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1265-1276. doi: 10.1080/03639045.2019.1594885. Epub 2019 May 17.
3
Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.新型载姜黄素混合胶束提高人肺癌细胞的口服生物利用度和抗癌活性。
Phytomedicine. 2015 Nov 15;22(12):1103-11. doi: 10.1016/j.phymed.2015.08.006. Epub 2015 Aug 28.
4
Enhanced oral bioavailability and anti-gout activity of [6]-shogaol-loaded solid lipid nanoparticles.载[6]-姜烯酚固体脂质纳米粒提高其口服生物利用度和抗痛风活性。
Int J Pharm. 2018 Oct 25;550(1-2):24-34. doi: 10.1016/j.ijpharm.2018.08.028. Epub 2018 Aug 17.
5
Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.载有 TPGS 的胶束通过热敏型鼻内凝胶给药在长春西汀脑内递送上的优势。
Int J Nanomedicine. 2019 Jul 23;14:5555-5567. doi: 10.2147/IJN.S213086. eCollection 2019.
6
Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles.去甲斑蝥素负载的聚乙二醇-聚己内酯两亲性嵌段共聚物胶束的制备、表征及抗癌活性
Pharmazie. 2012 Sep;67(9):781-8.
7
Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation.谷胱甘肽敏感的聚乙二醇化姜黄素前药纳米胶束的制备、表征、细胞摄取和生物利用度评价。
Int J Pharm. 2019 Jan 30;555:270-279. doi: 10.1016/j.ijpharm.2018.11.049. Epub 2018 Nov 22.
8
Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.新型染料木黄酮载药混合胶束系统的制备、表征及药代动力学研究。
Drug Dev Ind Pharm. 2018 Sep;44(9):1536-1542. doi: 10.1080/03639045.2018.1483384. Epub 2018 Jun 21.
9
PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment.聚乳酸-羟基乙酸共聚物-聚乙二醇-聚乳酸-羟基乙酸共聚物三嵌段共聚物胶束作为口服给药系统:体外药物释放及体内药代动力学评估
J Colloid Interface Sci. 2017 Mar 15;490:542-552. doi: 10.1016/j.jcis.2016.11.089. Epub 2016 Nov 26.
10
Preparation and evaluation of 6-Gingerol TPGS/PEG-PCL polymeric micelles.6-姜酚 TPGS/PEG-PCL 聚合物胶束的制备与评价。
Pharm Dev Technol. 2020 Jan;25(1):1-8. doi: 10.1080/10837450.2018.1558239. Epub 2019 Nov 12.

引用本文的文献

1
Preparation of a minocycline polymer micelle thermosensitive gel and its application in spinal cord injury.米诺环素聚合物胶束热敏凝胶的制备及其在脊髓损伤中的应用。
Nanoscale Adv. 2024 Sep 16;6(23):5874-88. doi: 10.1039/d4na00625a.
2
Review of the anticancer properties of 6-shogaol: Mechanisms of action in cancer cells and future research opportunities.6-姜烯酚的抗癌特性综述:癌细胞中的作用机制及未来研究机遇
Food Sci Nutr. 2024 Mar 27;12(7):4513-4533. doi: 10.1002/fsn3.4129. eCollection 2024 Jul.
3
Anticancer perspective of 6-shogaol: anticancer properties, mechanism of action, synergism and delivery system.

本文引用的文献

1
Heat-induced conversion of gingerols to shogaols in ginger as affected by heat type (dry or moist heat), sample type (fresh or dried), temperature and time.受热类型(干热或湿热)、样品类型(新鲜或干燥)、温度和时间影响,生姜中姜辣素受热转化为姜烯酚的过程。
Food Sci Biotechnol. 2017 Dec 29;27(3):687-693. doi: 10.1007/s10068-017-0301-1. eCollection 2018 Jun.
2
Nine New Gingerols from the Rhizoma of Zingiber officinale and Their Cytotoxic Activities.九种来自姜根茎的新姜酚及其细胞毒性活性。
Molecules. 2018 Feb 2;23(2):315. doi: 10.3390/molecules23020315.
3
Controlling and Predicting Nanoparticle Formation by Block Copolymer Directed Rapid Precipitations.
6-姜烯酚的抗癌前景:抗癌特性、作用机制、协同作用及递送系统
Chin Med. 2023 Oct 24;18(1):138. doi: 10.1186/s13020-023-00839-0.
4
6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure.6-姜酚,生姜的一种活性成分,抑制 p300 组蛋白乙酰转移酶活性,并减轻压力超负荷诱导的心力衰竭的发展。
Nutrients. 2023 May 8;15(9):2232. doi: 10.3390/nu15092232.
5
Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells.生姜成分6-姜辣素抑制原代人内皮细胞中与炎症和血管生成相关的细胞功能。
Front Pharmacol. 2022 Feb 25;13:844767. doi: 10.3389/fphar.2022.844767. eCollection 2022.
6
Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review.6-姜烯酚是否对低危骨髓增生异常综合征患者有效?一项叙述性综述。
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211065038. doi: 10.1177/15347354211065038.
7
Mechanisms of Chemopreventive and Therapeutic Proprieties of Ginger Extracts in Cancer.姜提取物在癌症中的化学预防和治疗特性的机制。
Int J Mol Sci. 2021 Jun 20;22(12):6599. doi: 10.3390/ijms22126599.
8
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study.植物生物活性化合物作为严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)主要蛋白酶(M)和刺突(S)糖蛋白抑制剂的潜力:一项分子对接研究。
Scientifica (Cairo). 2020 Dec 23;2020:6307457. doi: 10.1155/2020/6307457. eCollection 2020.
9
6-Shogaol Suppresses 2-Amino-1-Methyl-6-Phenylimidazo [4,5-b] Pyridine (PhIP)-Induced Human 786-O Renal Cell Carcinoma Osteoclastogenic Activity and Metastatic Potential.6-姜烯酚抑制 2-氨基-1-甲基-6-苯基咪唑[4,5-b]吡啶(PhIP)诱导的人 786-O 肾癌细胞破骨细胞生成活性和转移潜能。
Nutrients. 2019 Sep 28;11(10):2306. doi: 10.3390/nu11102306.
通过嵌段共聚物定向快速沉淀控制和预测纳米颗粒的形成。
Nano Lett. 2018 Feb 14;18(2):1139-1144. doi: 10.1021/acs.nanolett.7b04674. Epub 2018 Jan 10.
4
6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.6-姜烯酚诱导头颈部鳞状细胞癌细胞凋亡并增强放射敏感性。
Phytother Res. 2018 Feb;32(2):340-347. doi: 10.1002/ptr.5982. Epub 2017 Nov 23.
5
A novel formulation of [6]-gingerol: Proliposomes with enhanced oral bioavailability and antitumor effect.一种新型[6]-姜烯酚制剂:具有增强口服生物利用度和抗肿瘤作用的前体脂质体。
Int J Pharm. 2018 Jan 15;535(1-2):308-315. doi: 10.1016/j.ijpharm.2017.11.006. Epub 2017 Nov 7.
6
Transcriptome analysis reveals the genetic basis underlying the biosynthesis of volatile oil, gingerols, and diarylheptanoids in ginger (Zingiber officinale Rosc.).转录组分析揭示了生姜(姜科姜属植物)中挥发油、姜辣素和二芳基庚烷类化合物生物合成的遗传基础。
Bot Stud. 2017 Oct 23;58(1):41. doi: 10.1186/s40529-017-0195-5.
7
Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy.由单二硫键桥连杠柳毒苷 - 维生素E共轭物形成的用于肝癌化疗的氧化还原响应性聚乙二醇化自组装前药纳米颗粒。
Drug Deliv. 2017 Nov;24(1):1170-1178. doi: 10.1080/10717544.2017.1365393.
8
6-shogaol induces autophagic cell death then triggered apoptosis in colorectal adenocarcinoma HT-29 cells.6-姜烯酚诱导结直肠腺癌细胞 HT-29 发生自噬性细胞死亡继而引发细胞凋亡。
Biomed Pharmacother. 2017 Sep;93:208-217. doi: 10.1016/j.biopha.2017.06.038. Epub 2017 Jun 20.
9
Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles.载紫杉醇混合胶束的口服吸收改善及抗肺癌活性
Drug Deliv. 2017 Nov;24(1):261-269. doi: 10.1080/10717544.2016.1245370.
10
Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.用于提高靶向性和抗肿瘤效率的奥曲肽-杠柳毒苷共轭前药:合成、体外和体内评价
Oncotarget. 2016 Dec 27;7(52):86326-86338. doi: 10.18632/oncotarget.13389.